Trial reportJournal of the International Association of Providers of AIDS Care
Effects of Integrated Community-Based Care and Group Microfinance on Antiretroviral Therapy Adherence Among Adults Living With HIV in Western Kenya.
Trial report in Journal of the International Association of Providers of AIDS Care. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundDespite the introduction of single-pill antiretroviral therapy (ART), adherence remains suboptimal in Sub-Saharan Africa. The Harambee study evaluated the effects of delivering integrated community-based (ICB) HIV care within small lending and savings groups called microfinance groups in western Kenya. Here, we explore the intervention's, a 2-arm cluster randomized trial, impact on ART adherence.MethodsWe calculated the medication possession ratio (MPR) across 18 months at 3 time points using ART refill data from May 2021 to July 2023. As a secondary outcome, we assessed patient-reported 4-day ART adherence changes between study months 0 and 18. Outcomes were analyzed using linear regression models with treatment-by-time interaction terms to estimate time-varying treatment effects and month fixed effects, with standard errors clustered at the appropriate group level.ResultsBaseline mean MPRs were 0.971 for microfinance group members receiving ICB care, 0.989 for microfinance groups receiving usual (facility-based) care, and 0.995 for frequency-matched usual care patients not engaged in microfinance. At 18 months, MPRs were significantly higher among microfinance groups receiving usual care (0.057,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.